Glenmark Pharmaceuticals   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Mumbai India (1997)
Status: No NME R&D (1997)

Organization Overview

First Clinical Trial
2008
NCT00836940
First Marketed Drug
1997
nystatin (mycostatin)
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

GLENMARK | Glenmark Farmacêutica Ltda | GLENMARK GENERICS | Glenmark Pharamceuticals SA | Glenmark Pharmaceuticals | Glenmark Pharmaceutical S.A | Glenmark Pharmaceuticals Europe Ltd. (R&D) | Glenmark Pharmaceuticals Inc., USA | Glenmark Pharmaceuticals Ltd | Glenmark Pharmaceuticals Ltd. | Glenmark Pharmaceuticals Ltd. India | Glenmark Pharmaceuticals S.A. | GLENMARK PHARMS | GLENMARK PHARMS INC | GLENMARK PHARMS LTD | GLENMARK PHARMS SA | Glenmark Specialty S.A.